Mike Kratky
Stock Analyst at Leerink Partners
(4.47)
# 263
Out of 4,479 analysts
24
Total ratings
57.14%
Success rate
33.03%
Average return
Main Sectors:
Top Industries:
19 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNDM Tandem Diabetes Care | Upgrades: Outperform | $34 → $45 | $39.45 | +14.07% | 2 | Apr 25, 2024 | |
| NPCE NeuroPace | Initiates: Outperform | $22 | $7.32 | +200.55% | 1 | Jan 30, 2024 | |
| AXNX Axonics | Downgrades: Market Perform | $71 | $67.30 | +5.50% | 2 | Jan 12, 2024 | |
| PODD Insulet | Initiates: Outperform | $184 | $196.16 | -6.20% | 1 | Oct 16, 2023 | |
| VCEL Vericel | Initiates: Outperform | $42 | $45.03 | -6.73% | 1 | Oct 16, 2023 | |
| ISRG Intuitive Surgical | Initiates: Outperform | $342 | $436.24 | -21.60% | 1 | Oct 16, 2023 | |
| INSP Inspire Medical Systems | Initiates: Market Perform | $159 | $138.71 | +14.63% | 1 | Oct 16, 2023 | |
| EW Edwards Lifesciences | Initiates: Market Perform | $75 | $90.25 | -16.90% | 1 | Oct 16, 2023 | |
| DXCM DexCom | Initiates: Outperform | $110 | $112.17 | -1.93% | 1 | Oct 16, 2023 | |
| PRCT PROCEPT BioRobotics | Initiates: Outperform | $37 | $61.87 | -40.20% | 1 | Oct 16, 2023 | |
| AXGN AxoGen | Initiates: Outperform | $9 | $7.71 | +16.73% | 1 | Oct 16, 2023 | |
| GLTO Galecto | Downgrades: Market Perform | $13 → $2 | $0.47 | +329.09% | 2 | Aug 15, 2023 | |
| PLRX Pliant Therapeutics | Maintains: Outperform | $33 → $45 | $10.86 | +314.36% | 2 | Jan 24, 2023 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Outperform | $145 → $315 | $279.31 | +12.78% | 1 | Dec 20, 2022 | |
| KYMR Kymera Therapeutics | Maintains: Market Perform | $26 → $31 | $30.95 | +0.16% | 2 | Dec 15, 2022 | |
| IMVT Immunovant | Maintains: Outperform | $12 → $14 | $27.51 | -49.11% | 1 | Nov 4, 2022 | |
| VRDN Viridian Therapeutics | Maintains: Outperform | $32 → $40 | $13.21 | +202.80% | 1 | Aug 15, 2022 | |
| RAPT RAPT Therapeutics | Maintains: Outperform | $49 → $48 | $2.88 | +1,566.67% | 1 | Aug 11, 2022 | |
| MORF Morphic Holding | Initiates: Outperform | $45 | $32.55 | +38.25% | 1 | Jul 20, 2022 |
Tandem Diabetes Care
Apr 25, 2024
Upgrades: Outperform
Price Target: $34 → $45
Current: $39.45
Upside: +14.07%
NeuroPace
Jan 30, 2024
Initiates: Outperform
Price Target: $22
Current: $7.32
Upside: +200.55%
Axonics
Jan 12, 2024
Downgrades: Market Perform
Price Target: $71
Current: $67.30
Upside: +5.50%
Insulet
Oct 16, 2023
Initiates: Outperform
Price Target: $184
Current: $196.16
Upside: -6.20%
Vericel
Oct 16, 2023
Initiates: Outperform
Price Target: $42
Current: $45.03
Upside: -6.73%
Intuitive Surgical
Oct 16, 2023
Initiates: Outperform
Price Target: $342
Current: $436.24
Upside: -21.60%
Inspire Medical Systems
Oct 16, 2023
Initiates: Market Perform
Price Target: $159
Current: $138.71
Upside: +14.63%
Edwards Lifesciences
Oct 16, 2023
Initiates: Market Perform
Price Target: $75
Current: $90.25
Upside: -16.90%
DexCom
Oct 16, 2023
Initiates: Outperform
Price Target: $110
Current: $112.17
Upside: -1.93%
PROCEPT BioRobotics
Oct 16, 2023
Initiates: Outperform
Price Target: $37
Current: $61.87
Upside: -40.20%
AxoGen
Oct 16, 2023
Initiates: Outperform
Price Target: $9
Current: $7.71
Upside: +16.73%
Galecto
Aug 15, 2023
Downgrades: Market Perform
Price Target: $13 → $2
Current: $0.47
Upside: +329.09%
Pliant Therapeutics
Jan 24, 2023
Maintains: Outperform
Price Target: $33 → $45
Current: $10.86
Upside: +314.36%
Madrigal Pharmaceuticals
Dec 20, 2022
Maintains: Outperform
Price Target: $145 → $315
Current: $279.31
Upside: +12.78%
Kymera Therapeutics
Dec 15, 2022
Maintains: Market Perform
Price Target: $26 → $31
Current: $30.95
Upside: +0.16%
Immunovant
Nov 4, 2022
Maintains: Outperform
Price Target: $12 → $14
Current: $27.51
Upside: -49.11%
Viridian Therapeutics
Aug 15, 2022
Maintains: Outperform
Price Target: $32 → $40
Current: $13.21
Upside: +202.80%
RAPT Therapeutics
Aug 11, 2022
Maintains: Outperform
Price Target: $49 → $48
Current: $2.88
Upside: +1,566.67%
Morphic Holding
Jul 20, 2022
Initiates: Outperform
Price Target: $45
Current: $32.55
Upside: +38.25%